Therapeutic Interventions for Music Performance Anxiety: A Systematic Review and Narrative Synthesis.

The review examined any therapeutic intervention tested specifically for Music Performance Anxiety (MPA) — the intense, often debilitating fear of performing music in front of others. The interventions fell into four categories:

**Psychological therapies:** Cognitive-Behavioural Therapy (CBT), Acceptance and Commitment Therapy (ACT), and mindfulness-based interventions. These aim to change how musicians think about and respond to performance situations.

**Body-based techniques:** Alexander Technique, Feldenkrais Method, and yoga. These focus on reducing physical tension and improving body awareness during performance.

**Pharmacological interventions:** Beta-blockers (primarily propranolol) — medications that block adrenaline receptors, reducing heart rate, tremor, and sweating without significant sedation.

**Other:** Biofeedback, hypnotherapy, and music therapy.

The comparators were typically waitlist controls, no-treatment controls, or placebo pills (for medication studies). Some studies compared one active intervention against another.

Outcome measures included:

Self-reported anxiety scales (e.g., Music Performance Anxiety Inventory, State-Trait Anxiety Inventory)

Physiological measures (heart rate, blood pressure, cortisol levels)

Performance quality ratings (by blinded judges or self-report)

Behavioural measures (avoidance of performance opportunities)

The review synthesised data from **17 studies** with a total of **approximately 680 participants** (exact total not calculable from the review due to incomplete reporting in some studies).

**Population:** Musicians of all levels — from conservatoire students to professional orchestral players and soloists.

**Age range:** 18–65 years, with most participants in their 20s and 30s.

**Gender:** Approximately 60% female, 40% male across studies.

**Setting:** University music departments, conservatoires, professional orchestras, and private music teaching studios. Studies were conducted in the UK, USA, Australia, Germany, and the Netherlands.

**Exclusion criteria:** Most studies excluded musicians with current severe psychiatric disorders (e.g., psychosis, active substance dependence) or those already taking beta-blockers or other anxiety medications.

The review extracted data from studies using a variety of validated instruments:

**Music Performance Anxiety Inventory (MPAI):** A 20-item self-report scale (0–80 range, higher = worse anxiety) specifically designed for musicians. This was the most common primary outcome.

**State-Trait Anxiety Inventory (STAI):** Two 20-item scales measuring current anxiety (state) and general anxiety tendency (trait). Scores range 20–80 per scale.

**Kenny Music Performance Anxiety Inventory (K-MPAI):** A more comprehensive 40-item scale covering somatic, cognitive, and behavioural aspects of MPA.

**Physiological measures:** Heart rate (beats per minute via ECG or pulse oximeter), blood pressure (systolic/diastolic mmHg), and salivary cortisol (nmol/L) — typically measured immediately before, during, and after a performance.

**Performance quality:** Assessed by blinded expert judges using standardised rating scales (e.g., 1–10 for technical accuracy, musicality, and overall impression) or by self-report.

**Behavioural measures:** Number of performance opportunities taken up, avoidance behaviours, and dropout rates from performance courses.

**Study design:** This is a systematic review with narrative synthesis — meaning the authors systematically searched for all relevant studies, assessed their quality, and then summarised the findings in words rather than statistically pooling them (meta-analysis was not possible due to heterogeneity in interventions, populations, and outcome measures).

**Search strategy:** The authors searched five electronic databases (PubMed, PsycINFO, Web of Science, Scopus, and Google Scholar) from database inception to December 2024. They also hand-searched reference lists of included studies and relevant review articles.

**Inclusion criteria:**

Randomised controlled trials (RCTs), quasi-experimental studies, or pre-post designs with a control group

Published in peer-reviewed journals in English

Tested any intervention specifically for MPA

Included at least one validated outcome measure of MPA

**Exclusion criteria:** Case studies, qualitative studies only, studies of general performance anxiety not specific to music, and studies where MPA was a secondary outcome.

**Quality assessment:** The authors used the Cochrane Risk of Bias tool for RCTs and the ROBINS-I tool for non-randomised studies. Each study was rated as low, moderate, or high risk of bias.

**What this design can prove:** A systematic review provides the strongest available evidence for intervention effectiveness — but only if the included studies are high quality. The narrative synthesis approach allows the authors to discuss patterns across studies even when statistical pooling is impossible.

**What this design cannot prove:** Because this is a review of existing studies, it inherits all the limitations of those studies. The authors cannot establish causation beyond what the original RCTs demonstrated. The narrative synthesis is also more subjective than a meta-analysis — the authors' interpretation of patterns may differ from another reviewer's.

**Major methodological weaknesses flagged by the authors:**

Only 7 of 17 studies were true RCTs with adequate randomisation

Only 3 studies used blinding of participants or assessors

Sample sizes were small (median n = 32 per study)

Follow-up periods were short (most were 4–12 weeks, only 2 studies had follow-up beyond 6 months)

High heterogeneity in outcome measures made direct comparison difficult

Publication bias likely (studies with null results are less likely to be published)

**Primary outcomes (self-reported MPA):**

**CBT interventions** (6 studies): Showed consistent reductions in MPA scores. Effect sizes ranged from d = 0.6 to d = 1.2 (moderate to large). In the largest RCT (n = 64 conservatoire students), CBT reduced MPAI scores by an average of 12.4 points (95% CI: 8.1–16.7) compared to 3.2 points in the waitlist control (p < 0.001). Benefits were maintained at 6-month follow-up in 2 studies.

**Beta-blockers** (4 studies): Reduced physiological symptoms rapidly. Heart rate decreased by 15–25 bpm during performance (p < 0.01 across studies). Self-reported MPA scores decreased by d = 0.5–0.8 (moderate effect). However, 2 studies found that beta-blockers did not improve performance quality ratings by blinded judges — musicians felt calmer but did not actually play better.

**Alexander Technique** (3 studies): Reduced MPA scores by d = 0.7–1.0 (moderate to large). One RCT (n = 48) found that 8 weekly Alexander Technique sessions reduced MPAI scores by 10.1 points (SD = 8.3) versus 2.4 points (SD = 7.1) in the control group (p = 0.002). Benefits persisted at 3-month follow-up.

**Mindfulness/ACT** (3 studies): Mixed results. One study showed moderate reductions (d = 0.5), but two studies found no significant difference from controls. The positive study had a high dropout rate (35%).

**Biofeedback** (1 study): Small effect (d = 0.3), not statistically significant (p = 0.12).

**Secondary outcomes:**

**Performance quality (blinded judges):** Only CBT and Alexander Technique showed improvements in judged performance quality (d = 0.4–0.6, p < 0.05). Beta-blockers and mindfulness did not improve judged quality.

**Physiological measures:** Beta-blockers were most effective at reducing heart rate and blood pressure (d = 0.8–1.1). CBT and Alexander Technique showed smaller physiological reductions (d = 0.3–0.5).

**Avoidance behaviours:** CBT reduced avoidance of performance opportunities by 40–60% across studies (measured by self-report of number of performances attended or declined).

**Dropout rates:** CBT studies had 10–15% dropout; beta-blocker studies had 5–10% dropout; Alexander Technique had 8–12% dropout. Mindfulness studies had the highest dropout at 25–35%.

To translate these numbers into plain English:

**CBT:** A musician scoring 55/80 on the MPAI (moderate-to-severe anxiety) would typically drop to around 43/80 after 8–12 sessions — moving from "I dread performances" to "I feel nervous but can cope." This is roughly the difference between a student who avoids all solo performances and one who volunteers for them.

**Beta-blockers:** A musician's heart rate during performance drops from around 110 bpm (racing) to 85–90 bpm (elevated but manageable). The subjective feeling shifts from "I'm shaking uncontrollably" to "I feel physically calm." However, the quality of the actual performance does not improve — the musician feels better but plays the same.

**Alexander Technique:** Similar magnitude to CBT — about a 10-point drop on the MPAI after 8 sessions. The mechanism is different: instead of changing thoughts, it changes physical habits of tension. Musicians report feeling "more grounded" and "less likely to grip" their instrument.

**Mindfulness:** The effects are smaller and less reliable. A positive result would be a 5–6 point drop on the MPAI, but about half of participants get no benefit.

**What the authors acknowledge:**

Small number of studies (17) with small sample sizes (median n = 32)

High risk of bias in many studies — only 7 of 17 were properly randomised, only 3 were blinded

Short follow-up periods — cannot assess long-term durability of effects

Publication bias likely — studies with null results may be missing

Cannot perform meta-analysis due to heterogeneity — the narrative synthesis is less precise

Most studies excluded musicians with severe MPA — findings may not generalise to the most affected individuals

**What a critical reader would add:**

**Self-report bias:** All primary outcomes were self-reported. Musicians who invest time in therapy may report improvement due to effort justification, not actual change.

**No active placebo:** In psychological intervention studies, participants knew they were receiving treatment. The "placebo effect" of simply being in a study and expecting improvement is not controlled for.

**Beta-blocker studies used single doses:** Most medication studies tested a single dose before one performance, not regular use. This tells us about acute symptom suppression, not treatment of the underlying condition.

**Performance quality measures are crude:** Blinded judges rated short performances (3–5 minutes) in artificial settings. Real-world performance quality (e.g., a 45-minute concerto) may respond differently.

**No cost-effectiveness data:** CBT requires 8–12 sessions with a trained therapist (cost: £800–£1,200 in the UK). Beta-blockers cost pennies per dose. The review does not discuss whether the larger effect of CBT justifies the higher cost.

**Industry funding:** Two beta-blocker studies were funded by pharmaceutical companies. No psychological intervention studies reported industry funding.

**Cultural limits:** All studies were in Western countries. MPA may manifest differently in musical traditions that emphasise different performance values (e.g., collective vs. individual performance).

For someone running their own n=1 experiment to reduce music performance anxiety:

### What to test (specific intervention and dose)

**Option A: Cognitive-Behavioural Therapy (CBT)**

**Dose:** 8–12 weekly sessions of 50–60 minutes with a therapist trained in CBT for anxiety. Self-directed CBT workbooks (e.g., "The Musician's Mind" or "The Anxiety and Phobia Workbook") can be a lower-cost alternative, but the evidence is strongest for therapist-led CBT.

**Key components to test:** Cognitive restructuring (identifying and challenging anxious thoughts like "I will mess up and everyone will laugh"), exposure hierarchy (gradually facing feared performance situations), and relaxation training (diaphragmatic breathing, progressive muscle relaxation).

**Option B: Beta-blockers (propranolol)**

**Dose:** 10–40 mg taken 60–90 minutes before a performance. Start with 10 mg to test tolerance. **WARNING: Beta-blockers require a prescription in most countries. Do not obtain them illegally. Consult a doctor — they can be dangerous for people with asthma, low blood pressure, or heart conditions.**

**Key test:** Compare a performance with beta-blocker vs. placebo (if you can obtain placebo pills from a pharmacy). Measure heart rate, subjective anxiety, and performance quality.

**Option C: Alexander Technique**

**Dose:** 8–12 weekly private lessons (30–45 minutes each) with a certified Alexander Technique teacher. Group classes may be less effective.

**Key components to test:** "Direction" (mental instructions for freeing the neck and lengthening the spine), "inhibition" (pausing before reacting to anxiety), and "constructive rest" (lying down in semi-supine position to release tension).

### Minimum meaningful duration

**CBT and Alexander Technique:** 8 weeks minimum. Benefits typically appear after 4–6 sessions but consolidate by session 8. Do not expect results after 1–2 sessions.

**Beta-blockers:** One performance is enough to test acute effects. However, testing whether regular use changes your relationship with performance anxiety would require 4–6 performances over 2–3 months.

**Mindfulness:** 8 weeks of daily practice (10–20 minutes/day) is the minimum tested in the positive study. The mixed evidence suggests you should be prepared for the possibility of no benefit.

### What to measure (specific metrics)

**Primary metric: Music Performance Anxiety Inventory (MPAI)**

Free online version available (search "MPAI questionnaire")

Score 0–80, higher = worse

Measure before starting intervention, then every 2 weeks during intervention, and 1 month after finishing

**Secondary metrics:**

**Heart rate during performance:** Use a chest-strap heart rate monitor (e.g., Polar H10) or a smartwatch with ECG. Measure resting heart rate (sitting quietly for 2 minutes), then heart rate during the 2 minutes before you walk on stage, during the first piece, and 5 minutes after finishing.

**Performance quality:** Record yourself (audio or video) for each test performance. Have a trusted colleague or teacher rate the recordings blind (they should not know which condition each recording is from). Use a 1–10 scale for: technical accuracy, musical expression, and overall impression.

**Subjective anxiety (0–10 scale):** Rate "How anxious do you feel right now?" immediately before, during, and after each performance.

**Avoidance behaviour:** Count how many performance opportunities you accept vs. decline each month.

### Key confounds to control for

**Performance difficulty:** Always test the same piece(s) at the same level of preparation. A difficult piece will naturally cause more anxiety than an easy one.

**Time of day:** Performances at different times have different cortisol levels. Test at the same time of day (e.g., always 7 PM).

**Audience:** Audience size and composition matter. A small audience of friends is less anxiety-provoking than a large audience of strangers. Standardise audience type (e.g., always 3–5 fellow musicians).

**Caffeine and alcohol:** Both affect heart rate and anxiety. Avoid caffeine for 4 hours before testing. Avoid alcohol for 24 hours before testing.

**Sleep:** Poor sleep increases anxiety. Track sleep quality (e.g., "slept well / slept poorly" each night before a test performance).

**Menstrual cycle (if applicable):** Anxiety sensitivity varies across the cycle. If possible, test at the same phase (e.g., always during the follicular phase, days 5–12).

**Practice before performance:** More practice reduces anxiety